Alnylam Pharmaceuticals Cash Flow from Operating Activities 2010-2025 | ALNY
Alnylam Pharmaceuticals cash flow from operating activities for the twelve months ending March 31, 2025 was $0.002B, a 103.44% decline year-over-year.
- Alnylam Pharmaceuticals annual cash flow from operating activities for 2024 was $-0.008B, a 107.98% decline from 2023.
- Alnylam Pharmaceuticals annual cash flow from operating activities for 2023 was $0.104B, a 119.24% decline from 2022.
- Alnylam Pharmaceuticals annual cash flow from operating activities for 2022 was $-0.541B, a 15.65% decline from 2021.